epithalon clinical trial Epithalon (40mg vials) - Peptide

The last decades witnessed the discovery of a significant number of biologically active peptides, including hormones, vasoactive peptides, and neuropeptides, as described in the literature [1]

These combinations can address multiple aspects of disease pathophysiology and provide better glycemic control than individual therapies

Most of the time, they were not failing

In laboratory research models, DSIP has been explored for its ability to influence sleep architecture, stress response pathways, and hormonal balance

Mechanistic investigations point to modulation of inflammatory cytokines such as TNF- and IL-6, along with altered extracellular matrix remodeling profiles